冠状动脉旁路移植术临床路径用药方案制订  

Clinic path of drug using of grafting of coronary artery bypass

作　　者：王欣[1] 侯杰[1] 肖丽[1] 董军[1] 

机构地区：[1]泰达国际心血管病医院

出　　处：《中国医院》2007年第9期20-22,共3页Chinese Hospitals

摘　　要：目的:制订临床路径中合理的用药方案。方法:临床医师制订法、病案回顾调查法和循证医学法。结果:阐述临床路径用药方案制订指导思想;临床路径用药方案制订框架,包括表单制定与方法步骤;以CABG为例介绍临床路径用药方案制订的过程与结果。结论:临床路径用药方案制订必须充分发挥临床药师的作用,采用PDCA循环过程,应用循证医学的最新成果,使得临床路径的用药方案更加合理有效。Objective： To design rational drug using plan in clinic path. Methods： questionnaire to doctors, medical records review and evidence based medicine. Results： vision and philosophy of drug using plan in clinic path were mentioned, drug using framework and stage of form list were designed. Process and result of drug using by CABG was introduced.. Conclusions： Clinical Pharmacists were very important in drug using designing. PDCA controlling and evidence based medicine were considered to make drug using plan more effective.

关 键 词：冠状动脉旁路移植术 临床路径 用药方案 

分 类 号：R197.32[医药卫生—卫生事业管理]